Modeling the public health response to bioterrorism: Using discrete event simulation to design antibiotic distribution denters

被引:72
作者
Hupert, N
Mushlin, AL
Callahan, MA
机构
[1] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA
[3] New York Presbyterian Hosp, New York, NY USA
关键词
bioterrorism; mass prophylaxis; discrete event simulation modeling; public health;
D O I
10.1177/027298902237709
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background. Post-exposure prophylaxis is a critical component of the public health response to bioterrorism, Computer simulation modeling may assist in designing antibiotic distribution centers for this task. Methods. The authors used discrete event simulation modeling to determine staffing levels for entry screening, triage, medical evaluation, and drug dispensing stations in a hypothetical antibiotic distribution center operating in low, medium, and high disease prevalence bioterrorism response scenarios. Patient arrival rates and processing times were based on prior mass prophylaxis campaigns. Multiple sensitivity analyses examined the relationship between average staff utilization rate (UR) (i.e., percentage of time occupied in patient contact) and capacity of the model to handle surge arrivals, Results. Distribution center operation required from 93 staff for the low-prevalence scenario to 111 staff for the high-prevalence scenario to process approximately 1000 people per hour within the baseline model assumptions, Excess capacity to process surge arrivals approximated (1-UR) for triage staffing. Conclusions. Discrete event simulation modeling is a useful tool in developing the public health infrastructure for bioterrorism response, Live exercises to validate the assumptions and outcomes presented here may improve preparedness to respond to bioterrorism.
引用
收藏
页码:S17 / S25
页数:9
相关论文
共 32 条
[1]  
[Anonymous], MED EC
[2]   Prevention of inhalational anthrax in the US outbreak [J].
Brookmeyer, R ;
Blades, N .
SCIENCE, 2002, 295 (5561) :1861-1861
[3]   Drug points - Allergy associated with ciprofloxacin [J].
Burke, P ;
Burne, SR .
BRITISH MEDICAL JOURNAL, 2000, 320 (7236) :679-679
[4]  
*CAP HLTH, 2000, MASS IMM CAMP GUID B
[5]  
Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P909
[6]   Clinical and epidemiologic principles of anthrax [J].
Cieslak, TJ ;
Eitzen, EM .
EMERGING INFECTIOUS DISEASES, 1999, 5 (04) :552-555
[7]   Clinical recognition and management of patients exposed to biological warfare agents [J].
Franz, DR ;
Jahrling, PB ;
Friedlander, AM ;
McClain, DJ ;
Hoover, DL ;
Bryne, WR ;
Pavlin, JA ;
Christopher, CW ;
Eitzen, EM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (05) :399-411
[8]   Simulation optimization [J].
Fu, MC .
WSC'01: PROCEEDINGS OF THE 2001 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, 2001, :53-61
[9]   Anthrax as a biological weapon, 2002 - Updated recommendations for management [J].
Inglesby, TV ;
O'Toole, T ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Friedlander, AM ;
Gerberding, J ;
Hauer, J ;
Hughes, J ;
McDade, J ;
Osterholm, MT ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (17) :2236-2252
[10]   Plague as a biological weapon - Medical and public health management [J].
Inglesby, TV ;
Dennis, DT ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Fine, AD ;
Friedlander, AM ;
Hauer, J ;
Koerner, JF ;
Layton, M ;
McDade, J ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Schoch-Spana, M ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (17) :2281-2290